Healthcare Unusual Volume: MEI Pharma (NASDAQ:MEIP), Alimera Sciences Inc (NASDAQ:ALIM), Momenta Pharmaceuticals (NASDAQ:MNTA), Nordion Inc (NYSE:NDZ)
MEI Pharma Inc (NASDAQ:MEIP) just hit a fresh high moving above the psychologically-important $10 per share level for the first time. This mark is very close to the 52 week high for MEI Pharma which has added more than 46% in the last 12 weeks, suggesting that decent momentum is present in MEIP. MEI Pharma Inc (NASDAQ:MEIP) shares after opening at $11.54 on last trade day and at the end of the day closed at $11.13. Company price to cash ratio in past twelve months was calculated as 4.00. MEI Pharma Inc (NASDAQ:MEIP) showed a positive weekly performance of 16.54%.
Alimera Sciences (NASDAQ:ALIM) had its price objective raised by Northland Securities to $7.00 in a research report released on Monday morning, AnalystRatings.Net reports. Alimera Sciences Inc (NASDAQ:ALIM) shares advanced9.58% in last trading session and ended the day on $7.89. ALIM return on equity ratio is recorded as 296.40% and its return on assets is -198.80%. Alimera Sciences Inc (NASDAQ:ALIM) yearly performance is 160.40%.
Momenta Pharmaceuticals (NASDAQ:MNTA) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “Momenta Pharmaceuticals (MNTA) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share.” Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares moved down -16.85% in last trading session and was closed at $11.65, while trading in range of $11.26 – $14.15. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) year to date (YTD) performance is -34.11%.
Equities researchers at Canaccord Genuity decreased their target price on shares of Nordion Inc. Nordion Inc (USA) (NYSE:NDZ) from C$12.75 to C$11.75 in a research report issued on Monday, StockRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity’s price target would suggest a potential downside of 7.77% from the company’s current price. Nordion Inc(USA) (NYSE:NDZ)weekly performance is 9.51%. On last trading day company shares ended up $11.52. Nordion Inc(USA) (NYSE:NDZ) distance from 50-day simple moving average (SMA50) is16.60%. Analysts mean target price for the company is $11.12.